Spirulina Derivative for Radiation Esophagitis

• Status: NOT_YET_RECRUITING
• Trial end date: 2026-08-31

Summary

To evaluate the efficacy and safety of a Spirulina-derived product in preventing and treating radiation-induced esophagitis in esophageal cancer patients undergoing intensity-modulated radiotherapy (IMRT).

• Phase: PHASE2

Details

• Lead Sponsor: West China Hospital
• Treatments: Radiotherapy